The Role of Active and Passive Smoking in Chronic Obstructive Pulmonary Disease and Systemic Inflammation: A 12-year Prospective Study in China
- PMID: 39225766
- PMCID: PMC11442906
- DOI: 10.1007/s44197-024-00290-w
The Role of Active and Passive Smoking in Chronic Obstructive Pulmonary Disease and Systemic Inflammation: A 12-year Prospective Study in China
Abstract
Background: There is no consensus on the cause and effect of systemic chronic inflammation (SCI) regarding chronic obstructive pulmonary disease (COPD). The impact of second-hand smoke (SHS) on COPD has reached inconsistent conclusions.
Methods: The China Kadoorie Biobank cohort was followed up from the 2004-08 baseline survey to 31 December 2018. Among the selected 445,523 participants in the final analysis, Cox and linear regressions were performed to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of tobacco exposure with COPD risk and baseline levels of log-transformed inflammatory factors [βs (95% CIs)], respectively.
Results: Participants were followed up for a median of 12.1 years and 11,825 incident COPD events were documented. Ever-smokers were associated with a higher risk of COPD than non-smokers with non-weekly SHS exposure. A younger age to start smoking, a greater amount of daily tobacco consumption, and deeper inhalation were associated with increased risk of COPD and correlated with elevated levels of plasma high-sensitivity C-reactive protein (hs-CRP, all Ptrend < 0.001) even two years before COPD onset. Among former smokers, COPD risk declined with longer smoking cessation (Ptrend < 0.001) and those quitting smoking for over ten years presented no difference in COPD risk and hs-CRP level from non-smokers [HR (95% CI) = 1.05 (0.89, 1.25), β (95% CI) = 0.17 (- 0.09, 0.43)]. Among non-smokers, weekly SHS exposure was associated with a slightly higher COPD risk [HR (95% CI) = 1.06 (1.01, 1.12)].
Conclusions: Incremental exposure to tobacco smoke was related to elevated SCI level before COPD onset, then an increase in COPD susceptibility. Quitting smoking as early as possible is suggested as a practical approach to reducing COPD risk in smokers. Given the high prevalence of both COPD and SHS exposure, the risk associated with SHS exposure deserves attention.
Keywords: Active smoking; Chronic obstructive pulmonary disease; Passive smoking; Prospective cohort study; Systemic inflammation.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis.COPD. 2015 Apr;12(2):182-9. doi: 10.3109/15412555.2014.922173. Epub 2014 Jul 1. COPD. 2015. PMID: 24983136 Free PMC article.
-
Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.Int J Chron Obstruct Pulmon Dis. 2013;8:473-82. doi: 10.2147/COPD.S50551. Epub 2013 Oct 2. Int J Chron Obstruct Pulmon Dis. 2013. PMID: 24124359 Free PMC article.
-
Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study.Lancet. 2007 Sep 1;370(9589):751-7. doi: 10.1016/S0140-6736(07)61378-6. Lancet. 2007. PMID: 17765524
-
[COPD 2011: are there other risk factors than tobacco?].Rev Med Suisse. 2011 Nov 16;7(317):2232-5. Rev Med Suisse. 2011. PMID: 22400351 Review. French.
-
COPD and tobacco smoke.Monaldi Arch Chest Dis. 2005 Dec;63(4):213-25. doi: 10.4081/monaldi.2005.623. Monaldi Arch Chest Dis. 2005. PMID: 16454221 Review.
Cited by
-
Association between blood heavy metal levels and COPD risk: a cross-sectional study based on NHANES data.Front Public Health. 2025 Jul 18;13:1494336. doi: 10.3389/fpubh.2025.1494336. eCollection 2025. Front Public Health. 2025. PMID: 40756396 Free PMC article.
-
Biocontrol toxicity of Trichoderma harzianum (Hypocreales: Hypocreaceae) derived chemical molecules against malarial mosquito Anopheles stephensi with molecular docking studies.Biotechnol Lett. 2024 Dec 13;47(1):12. doi: 10.1007/s10529-024-03542-8. Biotechnol Lett. 2024. PMID: 39671011
-
The burden of malaria in East Africa: prevalence, risk factors, and control strategies.Malar J. 2025 Aug 8;24(1):255. doi: 10.1186/s12936-025-05492-6. Malar J. 2025. PMID: 40781311 Free PMC article. Review.
References
-
- Disease GIfCOL: Global strategy for the diagnosis, management, and prevention of COPD: 2023 report. In.; 2022.
-
- Ge J, Xu Y, Wang C. Internal Medicine (9th edition). Beijing: People’s Medical Publishing House; 2018.
-
- Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. - PubMed
-
- Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of “overspill” of inflammatory mediators from the lungs? Review Evidence Thorax. 2010;65(10):930–6. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous